P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias. (12th March 2014) - Richard, K; Schober, S; Rami, M; Mall, S; Merl, J; Slotta-Huspenina, J; Stevanovic, S; Busch, DH; Peschel, C; Krackhardt, AM